Collagenesis Inc., Osiris deal

The companies will evaluate the use of Collagenesis' collagen-based biocompatible Tissue Matrix Delivery System (TMDS) to immobilize and deliver Osiris' mesenchymal stem cells to regenerate soft tissu...